TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES

Spoj, naznačen time, što je odabran iz skupine koja se sastoji od: ili njegova farmaceutski prihvatljiva sol ili otopina. Patent sadrži još 13 patentnih zahtjeva. Compounds of the formula below are poly(ADP-ribosyl)transferase (PARP) inhibitors, and are useful as therapeutics in treatment of cancers...

Full description

Saved in:
Bibliographic Details
Main Authors STEPHEN EVAN WEBBER, STACIE S. CANAN-KOCH, LARS HENRIK THORESEN, JAYASHREE GIRISH TIKHE
Format Patent
LanguageCroatian
English
Published 30.04.2006
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Spoj, naznačen time, što je odabran iz skupine koja se sastoji od: ili njegova farmaceutski prihvatljiva sol ili otopina. Patent sadrži još 13 patentnih zahtjeva. Compounds of the formula below are poly(ADP-ribosyl)transferase (PARP) inhibitors, and are useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease. As cancer therapeutics, the compounds of the invention may be used, e.g., in combination with cytotoxic agents and/or radiation.
Bibliography:Application Number: HR2001P000573